IRIS Accounts Production v23.2.0.158 05542912 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055429122022-03-31055429122023-03-31055429122022-04-012023-03-31055429122021-03-31055429122021-04-012022-03-31055429122022-03-3105542912ns10:Originalns15:EnglandWales2022-04-012023-03-3105542912ns14:PoundSterlingns10:Original2022-04-012023-03-3105542912ns10:Originalns10:Director12022-04-012023-03-3105542912ns10:Original2022-04-012023-03-3105542912ns10:Original2023-03-3105542912ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3105542912ns10:Originalns10:SmallEntities2022-04-012023-03-3105542912ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3105542912ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3105542912ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3105542912ns10:Originalns10:FullAccounts2022-04-012023-03-3105542912ns10:Originalns10:Director22022-04-012023-03-3105542912ns10:CompanySecretary1ns10:Original2022-04-012023-03-3105542912ns10:Originalns10:RegisteredOffice2022-04-012023-03-3105542912ns10:Original2022-03-3105542912ns10:Originalns5:CurrentFinancialInstruments2023-03-3105542912ns10:Originalns5:CurrentFinancialInstruments2022-03-3105542912ns5:ShareCapitalns10:Original2023-03-3105542912ns5:ShareCapitalns10:Original2022-03-3105542912ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3105542912ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3105542912ns10:Originalns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-04-012023-03-3105542912ns10:Originalns5:PlantMachinery2022-04-012023-03-3105542912ns10:Originalns5:FurnitureFittings2022-04-012023-03-3105542912ns10:Original2021-04-012022-03-3105542912ns10:Originalns5:LandBuildings2022-03-3105542912ns10:Originalns5:PlantMachinery2022-03-3105542912ns10:Originalns5:FurnitureFittings2022-03-3105542912ns10:Originalns5:MotorVehicles2022-03-3105542912ns10:Original2022-03-3105542912ns10:Originalns5:LandBuildings2022-04-012023-03-3105542912ns10:Originalns5:MotorVehicles2022-04-012023-03-3105542912ns10:Originalns5:LandBuildings2023-03-3105542912ns10:Originalns5:PlantMachinery2023-03-3105542912ns10:Originalns5:FurnitureFittings2023-03-3105542912ns10:Originalns5:MotorVehicles2023-03-3105542912ns10:Originalns5:LandBuildings2022-03-3105542912ns10:Originalns5:PlantMachinery2022-03-3105542912ns10:Originalns5:FurnitureFittings2022-03-3105542912ns10:Originalns5:MotorVehicles2022-03-3105542912ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3105542912ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31
REGISTERED NUMBER: 05542912 (England and Wales)



















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

FOR

LONDON DERMATOLOGY LIMITED

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LONDON DERMATOLOGY LIMITED

COMPANY INFORMATION
for the year ended 31 March 2023







DIRECTORS: Dr. H P Stevens
Mrs D Stevens





SECRETARY: Mrs D Stevens





REGISTERED OFFICE: London Dermatology Limited
52 The Chase
Clapham Old Town
London
SW4 0NH





REGISTERED NUMBER: 05542912 (England and Wales)





ACCOUNTANTS: Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

BALANCE SHEET
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 761,112 782,205

CURRENT ASSETS
Debtors 5 437,202 299,798
Cash at bank 48,605 287,002
485,807 586,800
CREDITORS
Amounts falling due within one year 6 144,140 274,963
NET CURRENT ASSETS 341,667 311,837
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,102,779

1,094,042

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 1,101,779 1,093,042
SHAREHOLDERS' FUNDS 1,102,779 1,094,042

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

BALANCE SHEET - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 October 2023 and were signed on its behalf by:





Dr. H P Stevens - Director


LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2023


1. STATUTORY INFORMATION

London Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Office equipment - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2023


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 3 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold Office and Motor
property equipment fittings vehicles Totals
£    £    £    £    £   
COST
At 1 April 2022 1,105,852 31,063 66,387 2,168 1,205,470
Additions - 2,240 - - 2,240
At 31 March 2023 1,105,852 33,303 66,387 2,168 1,207,710
DEPRECIATION
At 1 April 2022 325,902 30,082 65,234 2,047 423,265
Charge for year 22,117 806 289 121 23,333
At 31 March 2023 348,019 30,888 65,523 2,168 446,598
NET BOOK VALUE
At 31 March 2023 757,833 2,415 864 - 761,112
At 31 March 2022 779,950 981 1,153 121 782,205

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 29,994 108,802
Amounts owed by group undertakings 403,594 185,325
Other debtors 3,614 3,614
Prepayments - 2,057
437,202 299,798

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2023


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 129 -
Trade creditors 3,641 8,737
Amounts owed to group undertakings 25,173 25,256
Tax - 15,171
Social security and other taxes 427 168
Other creditors 17,060 17,060
Directors' current accounts 90,750 201,653
Accrued expenses 6,960 6,918
144,140 274,963

7. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   

8. ULTIMATE CONTROLLING PARTY



Dr H Stevens who is a director, and his family, own more than 50% of the share capital of London Dermatology Limited.